CMS RBCS · Treatments · Injections and Infusions (nononcologic)

Injection - Growth/Hormone Factor codes

2 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Treatment J9155 Injection, degarelix, 1 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 1.32M services · est. ▼ 29.2% YoY · 2,366 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 707,305 observed fee-for-service services

See the national market for J9155 → ranked groups · states · 12-yr trend

HCPCS · Treatment J9217 Leuprolide acetate (for depot suspension), 7.5 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 985,321 services · est. ▼ 11.1% YoY · 74,253 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 495,106 observed fee-for-service services

See the national market for J9217 → ranked groups · states · 12-yr trend